BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gui D, Dong Z, Peng W, Jiang W, Huang G, Liu G, Ye Z, Wang Y, Xu Z, Fu J, Luo S, Zhao Y. Ubiquitin-specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF-κB pathway inactivation. Cancer Med 2021;10:3674-88. [PMID: 33973730 DOI: 10.1002/cam4.3911] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hariri H, St-Arnaud R. Expression and Role of Ubiquitin-Specific Peptidases in Osteoblasts. Int J Mol Sci 2021;22:7746. [PMID: 34299363 DOI: 10.3390/ijms22147746] [Reference Citation Analysis]
2 Yao Y, Ma W, Guo Y, Liu Y, Xia P, Wu X, Chen Y, Wang K, Mei C, Wang G, Li X, Zhang Z, Chen X, Yuan Y. USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. Oncogenesis 2022;11:31. [PMID: 35654790 DOI: 10.1038/s41389-022-00404-8] [Reference Citation Analysis]